ATE458198T1 - Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten - Google Patents

Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten

Info

Publication number
ATE458198T1
ATE458198T1 AT02780858T AT02780858T ATE458198T1 AT E458198 T1 ATE458198 T1 AT E458198T1 AT 02780858 T AT02780858 T AT 02780858T AT 02780858 T AT02780858 T AT 02780858T AT E458198 T1 ATE458198 T1 AT E458198T1
Authority
AT
Austria
Prior art keywords
estimating
cell types
subtypes
specific
neutrophil cell
Prior art date
Application number
AT02780858T
Other languages
English (en)
Inventor
Per Venge
Original Assignee
Phadia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia Ab filed Critical Phadia Ab
Application granted granted Critical
Publication of ATE458198T1 publication Critical patent/ATE458198T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051T-cell receptor (TcR)-CD3 complex
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514CD4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517CD8
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452Thrombomodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02780858T 2001-06-25 2002-06-24 Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten ATE458198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102220A SE0102220D0 (sv) 2001-06-25 2001-06-25 Method for estimation of the amount of specific cell types
PCT/SE2002/001214 WO2003001205A1 (en) 2001-06-25 2002-06-24 Method for estimation of the amount of specific cell types

Publications (1)

Publication Number Publication Date
ATE458198T1 true ATE458198T1 (de) 2010-03-15

Family

ID=20284572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02780858T ATE458198T1 (de) 2001-06-25 2002-06-24 Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten

Country Status (10)

Country Link
EP (1) EP1407266B1 (de)
JP (1) JP2004532994A (de)
AT (1) ATE458198T1 (de)
AU (1) AU2002350797B2 (de)
CA (1) CA2447843A1 (de)
DE (1) DE60235368D1 (de)
DK (1) DK1407266T3 (de)
ES (1) ES2340472T3 (de)
SE (1) SE0102220D0 (de)
WO (1) WO2003001205A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008144850A1 (en) * 2007-05-30 2008-12-04 Advanced Diagnostic Systems Ltd Assay for determining risk of development of allergic disorders
WO2016043683A1 (en) * 2014-09-18 2016-03-24 Ciftci Ihsan Hakki A blood count device
CN114720358B (zh) * 2022-04-11 2022-09-27 浙江普罗亭健康科技有限公司 一种质谱流式血液肿瘤免疫分型中替代侧向散射光信号的抗体组合及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
JP3522865B2 (ja) * 1994-11-25 2004-04-26 株式会社いかがく 尿中白血球の検出方法
US5658745A (en) * 1995-02-17 1997-08-19 E. I. Du Pont De Nemours And Company Cell enumeration immunoassay
JP2000510581A (ja) * 1996-03-29 2000-08-15 ユニバーシティー オブ ブリティッシュ コロンビア 血小板顆粒蛋白質を用いた血小板数アッセイ
JP2000019170A (ja) * 1998-06-29 2000-01-21 Shima Kenkyusho:Kk 顆粒球数測定方法、白血球数測定方法及び白血球数測 定装置
EP1141726B1 (de) * 1999-01-14 2004-08-04 CA*TX, Inc. Immunoassays zum nachweis von krankheiten oder krankheitsanfälligkeitsmerkmalen
US6363802B1 (en) * 1999-03-25 2002-04-02 Coulter International Corp. Apparatus for aspirating liquid from a vessel
US6599713B1 (en) * 1999-03-29 2003-07-29 Asahi Kasei Kabushiki Kaisha Method for quantitating leukocyte count in whole blood sample

Also Published As

Publication number Publication date
DK1407266T3 (da) 2010-05-31
AU2002350797B2 (en) 2008-03-20
SE0102220D0 (sv) 2001-06-25
DE60235368D1 (de) 2010-04-01
JP2004532994A (ja) 2004-10-28
CA2447843A1 (en) 2003-01-03
WO2003001205A1 (en) 2003-01-03
EP1407266A1 (de) 2004-04-14
ES2340472T3 (es) 2010-06-04
EP1407266B1 (de) 2010-02-17

Similar Documents

Publication Publication Date Title
DE60327354D1 (de) Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort
MXPA05007062A (es) Metodo para fabricar biosensores integrados.
ATE417125T1 (de) Diagnose von einer klinischen infektion einer wunde
DE60325180D1 (de) Mikrovorrichtungen zur untersuchung von biologischen systemen
CY1105322T1 (el) Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων
BR0201823A (pt) Método para fornecimento de serviços diagnósticos clìnicos
Al-Muhtaseb Serum and saliva protein levels in females with breast cancer
EP1480251A3 (de) Analyse komplexer Mischungen von biologischen und anderen Flüssigkeiten zur Erfassung ihrer Biologischen Eigenschaften.
Mazon et al. Elevated blood levels of Dickkopf‐1 are associated with acute infections
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
JP2011503631A (ja) 創傷感染の診断マーカー
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
SE0000675D0 (sv) Monoclonal antibodies
ATE458198T1 (de) Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
Potdar et al. Association between cheiloscopic patterns and ABO blood groups among South Indian population
JP2006509500A5 (de)
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
WO2001056456A3 (en) Methods and compositions for detection of disease
Całkosiński et al. Dynamic analysis of changes of protein levels and selected biochemical indices in rat serum in the course of experimental pleurisy
WO2002103059A3 (en) Innate immunity markers for rapid diagnosis of infectious diseases
CN106093024A (zh) 一种检测脑卒中发病风险以及发病的生物标志物的检测方法及其应用
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
DE60317478D1 (de) Beurteilungen und mittel auf populationsbasis zur bestimmung der rangfolge der relativen immunogenität von proteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties